A herbal extract with acetyl-coenzyme A carboxylase inhibitory activity and its potential for treating metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 58, Issue 9, 2009, Pages 1297-1305

  Chen, Chi Hua ^a   Chang, Mei Yui ^b   Lin, Yu Shen ^b   Lin, Da Gin ^c   Chen, Shiow Wen ^a   Chao, Pei Min ^b  

^a FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TRANSWORLD INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALCOHOL; ENZYME INHIBITOR; FATTY ACID SYNTHASE; GLUCOSE; PLANT EXTRACT; POLYGONUM HYPOLEUCUM EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; IC 50; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; POLYGONUM; POLYGONUM HYPOLEUCUM; PRIORITY JOURNAL; RAT;

ACETYL-COA CARBOXYLASE; ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DIET, ATHEROGENIC; DIETARY FATS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; ETHANOL; HEPATOCYTES; LIPOGENESIS; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; POLYGONUM; RATS; RATS, WISTAR;

EID: 68549130618     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.012     Document Type: Article

References (36)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Plutzky J. Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr Opin Cardiol 15 (2000) 416-421
3. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44 (1995) 863-870
4. DeFronzo R.A. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 143 (2004) 9-21
5. Harwood H.J. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome. Curr Opin Investig Drugs 5 (2004) 283-289
6. Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell Mol Life Sci 62 (2005) 1784-1803
7. Munday M.R. Regulation of mammalian acetyl-CoA carboxylase. Biochem Soc Trans 30 (2002) 1059-1064
8. Abu-Elheiga L., Matzuk M.M., Abo-Hashema K.A., and Wakil S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291 (2001) 2613-2616
9. Savage D.B., Choi C.S., Samuel V.T., Liu Z.X., Zhang D., Wang A., et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116 (2006) 817-824
10. McCune S.A., and Harris R.A. Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. J Biol Chem 254 (1979) 10095-10101
11. Harwood H.J., Petras S.F., Shelly L.D., Zaccaro L.M., Perry D.A., Makowski M.R., et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem 278 (2003) 37099-37111
12. Kuo Y.C., Ou J.C., Tsai W.J., Wu C.L., and Sun C.M. Evaluation of Chinese herbs that affect the cell-mediated immunity (II). J Chinese Med 7 (1996) 119-131
13. Kuo Y.C., Sun C.M., Ou J.C., and Tsai W.J. A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci 61 (1997) 2335-2344
14. Kuo Y.C., Meng H.C., and Tsai W.J. Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. Inflamm Res 50 (2001) 73-82
15. Kuo Y.C., Tsai W.J., Meng H.C., Chen W.P., Yang L.Y., and Lin C.Y. Immune responses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi. Life Sci 68 (2001) 1271-1286
16. Tanabe T., Nakanishi S., Hashimoto T., Ogiwara H., Nikawa J., and Numa S. Acetyl-CoA carboxylase from rat liver. Methods Enzymol 71 Pt C (1981) 5-16
17. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
18. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279 (2004) 47898-47905
19. Nepokroeff C.M., Lakshmanan M.R., and Porter J.W. Fatty-acid synthase from rat liver. Methods Enzymol 35 (1975) 37-44
20. Parker R.A., Kariya T., Grisar J.M., and Petrow V. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. J Med Chem 20 (1977) 781-791
21. Triscari J., and Sullivan A.C. Antiobesity effects of a novel lipid synthesis inhibitor (Ro 22-0654). Life Sci 34 (1984) 2433-2442
22. Abu-Elheiga L., Matzuk M.M., Kordari P., Oh W., Shaikenov T., Gu Z., et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc Natl Acad Sci USA 102 (2005) 12011-12016
23. Abu-Elheiga L., Oh W., Kordari P., and Wakil S.J. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 100 (2003) 10207-10212
24. Choi C.S., Savage D.B., Abu-Elheiga L., Liu Z.X., Kim S., Kulkarni A., et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 104 (2007) 16480-16485
25. Mao J., DeMayo F.J., Li H., Abu-Elheiga L., Gu Z., Shaikenov T.E., et al. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA 103 (2006) 8552-8557
26. Wakil S.J., Stoops J.K., and Joshi V.C. Fatty acid synthesis and its regulation. Annu Rev Biochem 52 (1983) 537-579
27. Smith S. The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 8 (1994) 1248-1259
28. Watanabe J., Kawabata J., and Niki R. Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci Biotechnol Biochem 62 (1998) 532-534
29. Watanebe L., Kawabata J., and Kasai T. 9-Oxooctadeca-10,12-dienoic acids as acetyl-CoA carboxylase inhibitors from red pepper (Capsicum annuum L.). Biosci Biotechnol Biochem 63 (1999) 489-493
30. Hashimura H., Ueda C., Kawabata J., and Kasai T. Acetyl-CoA carboxylase inhibitors from avocado (Persea americana Mill) fruits. Biosci Biotechnol Biochem 65 (2001) 1656-1658
31. Ogiwara H., Tanabe T., Nikawa J., and Numa S. Inhibition of rat-liver acetyl-coenzyme-A carboxylase by palmitoyl-coenzyme A. Formation of equimolar enzyme-inhibitor complex. Eur J Biochem 89 (1978) 33-41
32. Pinent M., Blade C., Salvado M.J., Blay M., Pujadas G., Fernandez-Larrea J., et al. Procyanidin effects on adipocyte-related pathologies. Crit Rev Food Sci Nutr 46 (2006) 543-550
33. Saggerson D. Malonyl-CoA, a key signaling molecule in mammalian cells. Annu Rev Nutr 28 (2008) 253-272
34. Nolan C.J., Madiraju M.S., Delghingaro-Augusto V., Peyot M.L., and Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 55 (2006) S16-S23
35. Loftus T.M., Jaworsky D.E., Frehywot G.L., Townsend C.A., Ronnett G.V., Lane M.D., et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288 (2000) 2379-2381
36. Wolfgang M.J., and Lane M.D. The role of hypothalamic malonyl-CoA in energy homeostasis. J Biol Chem 281 (2006) 37265-37269